Stone X Group Inc. Becton Dickinson & CO Transaction History

Stone X Group Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Aug 13, 2025	BUY	$222.79 - $249.08 $81,541 - $91,163	366 Added 32.48%	1,493 $342 Million
Q4 2024 Aug 13, 2025	BUY	$220.02 - $243.75 $14,081 - $15,600	64 Added 6.02%	1,127 $256 Million
Q3 2024 Aug 13, 2025	SELL	$221.47 - $242.41 $48,058 - $52,602	-217 Reduced 16.95%	1,063 $256 Million
Q2 2024 Aug 13, 2025	BUY	$225.07 - $246.17 $288,089 - $315,097	1,280 New	1,280 $299 Million
Q1 2024 Aug 13, 2025	BUY	$233.45 - $247.73 $276,871 - $293,807	1,186 New	1,186 $294 Million

Q3 2023 Aug 13, 2025	SELL	$254.9 - $283.59 $7,137 - $7,940	-28 Reduced 2.84%	957 $247 Million
Q2 2023 Aug 13, 2025	BUY	$238.39 - $265.32 $234,814 - $261,340	985 New	985 $260 Million
Q1 2023 Aug 13, 2025	BUY	$229.71 - $259.35 $223,048 - $251,828	971 New	971 $240 Million
Q3 2017 Nov 13, 2017	SELL	$186.89 - $198.9 $1.77 Million - $1.88 Million	-9,459 Closed	0 $0
Q2 2017 Aug 31, 2017	BUY	N/A	9,459	9,459 $1.85 Million

1,717

257M

1.01M

544K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $54.5B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

Stay updated on Stone X Group Inc. with notifications on news.